Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Fobia social: perspectivas de diagnóstico, neurobiológicas y de tratamiento
1
x
$
0.00
Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders
1
x
$
30.00
A Comprehensive Review and Update of the Use of Dexmedetomidine for Regional Blocks
1
x
$
30.00
Advancing the Treatment of Anxiety Disorders: New Findings and Novel Uses for Atypical Antipsychotics
1
x
$
30.00
John S. Markowitz, PharmD: The Emerging Recognition of Herb-Drug Interactions With a Focus on St. John’s Wort (Hypericum Perforatum)
1
x
$
30.00
Ross A. Baker - Atypical Antipsychotic Drugs and Diabetes Mellitus in the US Food and Drug Administration Adverse Event Database: A Systematic Bayesian Signal Detection Analysis
1
x
$
30.00
Johannes Hamann, MD: How Long do Psychiatrists Wait for Response Before They Switch to Another Antipsychotic?
1
x
$
30.00
Quetiapine XR Negative Clinical Trials Report by Gang Wang
1
x
$
30.00
Late-Life Anxiety Disorders
1
x
$
30.00
View Cart
Checkout
Home
vicki-l-ellingrod
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Sex Differences in Antipsychotic Related Metabolic Functioning in Schizophrenia Spectrum Disorders
$
30.00
Add to cart
Details
Vicki L. Ellingrod, PharmD, BCPP: 5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia
$
30.00
Add to cart
Details
Vicki L. Ellingrod, PharmD, BCPP: Leptin and Leptin Receptor Gene Polymorphisms and Increases in Body Mass Index (BMI) from Olanzapine Treatment in Persons with Schizophrenia
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 47 No. 2, 2017 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
A Pilot Study of the Pharmacodynamic Impact of SSRI Drug Selection and Beta-1 Receptor Genotype (ADRB1) on Cardiac Vital Signs in Depressed Patients: A Novel Pharmacogenetic Approach
$
30.00
Add to cart
Details
Page load link
Go to Top
